Inventor
YAMADA KEN
JP34 patents
⚠️ This page may combine multiple inventors who share the name “YAMADA KEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAZDA MOTOR
10 patentsUS11052949B2Jul 6, 2021
Rear vehicle body structure
MAZDA MOTOR6 citations73
US9714052B2Jul 25, 2017
Rear vehicle-body structure of automotive vehicle
MAZDA MOTOR3 citations73
US11364957B2Jun 21, 2022
Rear vehicle-body structure of vehicle
MAZDA MOTOR2 citations66
US10940890B2Mar 9, 2021
Rear vehicle-body structure
MAZDA MOTOR1 citations62
US10730564B2Aug 4, 2020
Rear vehicle-body structure
MAZDA MOTOR1 citations62
US10293857B2May 21, 2019
Reach vehicle-body structure of vehicle
MAZDA MOTOR1 citations62
US10286955B2May 14, 2019
Rear vehicle-body structure of vehicle
MAZDA MOTOR1 citations62
US11142153B2Oct 12, 2021
Vehicle-body structure
MAZDA MOTOR0 citations52
US11040743B2Jun 22, 2021
Rear vehicle-body structure
MAZDA MOTOR0 citations51
US10730567B2Aug 4, 2020
Rear vehicle-body structure
MAZDA MOTOR0 citations41
UNIV MASSACHUSETTS
6 patentsUS11827882B2Nov 28, 2023
Modified oligonucleotides targeting SNPs
UNIV MASSACHUSETTS7 citations83
US12077758B2Sep 3, 2024
Oligonucleotides for SARS-CoV-2 modulation
UNIV MASSACHUSETTS2 citations62
US12146136B2Nov 19, 2024
Synthesis of modified oligonucleotides with increased stability
UNIV MASSACHUSETTS0 citations59
US12024706B2Jul 2, 2024
Modified oligonucleotides targeting SNPs
UNIV MASSACHUSETTS1 citations59
US11820985B2Nov 21, 2023
Modified oligonucleotides with increased stability
UNIV MASSACHUSETTS1 citations59
US12534724B2Jan 27, 2026
Synthetic oligonucleotides having regions of block and cluster modifications
UNIV MASSACHUSETTS0 citations48
MOGI MUNETO
4 patentsUS8440682B2May 14, 2013
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
MOGI MUNETO0 citations48
US8420641B2Apr 16, 2013
Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
MOGI MUNETO0 citations48
US8193349B2Jun 5, 2012
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
MOGI MUNETO0 citations48
US8759365B2Jun 24, 2014
Organic compounds
MOGI MUNETO0 citations39
YAMADA KEN
3 patentsNOVARTIS AG
3 patentsUS10844055B2Nov 24, 2020
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG1 citations70
US11530213B2Dec 20, 2022
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG0 citations59
US10266531B2Apr 23, 2019
Naphthyridinone derivatives and their use in the treatment of arrhythmia
NOVARTIS AG0 citations48